000 04005naa a22004937i 4500
001 UMUN-OA-20261005-MLS-033
003 local
005 20261005174904.0
006 m o d
007 cr||||||||||||
008 261005s2017 xx o u000 0 eng d
024 7 _a10.1007/s10096-017-3024-6
_2doi
035 _a(local)EuropePMC:PMC5653721
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aF Tagini
_eauthor.
245 1 0 _aBacterial genome sequencing in clinical microbiology: a pathogen-oriented review. /
_cF Tagini; G Greub.
264 1 _a[Place of publication not identified] :
_b[publisher not identified],
_c2017.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aIn recent years, whole-genome sequencing (WGS) has been perceived as a technology with the potential to revolutionise clinical microbiology. Herein, we reviewed the literature on the use of WGS for the most commonly encountered pathogens in clinical microbiology laboratories: Escherichia coli and other Enterobacteriaceae, Staphylococcus aureus and coagulase-negative staphylococci, streptococci and enterococci, mycobacteria and Chlamydia trachomatis. For each pathogen group, we focused on five different aspects: the genome characteristics, the most common genomic approaches and the clinical uses of WGS for (i) typing and outbreak analysis, (ii) virulence investigation and (iii) in silico antimicrobial susceptibility testing. Of all the clinical usages, the most frequent and straightforward usage was to type bacteria and to trace outbreaks back. A next step toward standardisation was made thanks to the development of several new genome-wide multi-locus sequence typing systems based on WGS data. Although virulence characterisation could help in various particular clinical settings, it was done mainly to describe outbreak strains. An increasing number of studies compared genotypic to phenotypic antibiotic susceptibility testing, with mostly promising results. However, routine implementation will preferentially be done in the workflow of particular pathogens, such as mycobacteria, rather than as a broadly applicable generic tool. Overall, concrete uses of WGS in routine clinical microbiology or infection control laboratories were done, but the next big challenges will be the standardisation and validation of the procedures and bioinformatics pipelines in order to reach clinical standards.
540 _aCreative Commons Attribution (licence family recorded by the source; version not supplied in metadata).
_uhttps://europepmc.org/articles/PMC5653721
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aGenomics
650 4 _aNext-generation Sequencing
650 4 _aWhole-genome Sequencing
650 4 _aClinical Microbiology
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _aclinical microbiology
655 4 _aReview articles.
700 0 _aG Greub
_eauthor.
773 0 _tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
_gVol. 36, no. 11, (2017), pages/article 2007-2020
_x0934-9723
856 4 0 _uhttps://europepmc.org/articles/PMC5653721
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC5653721
_qlocal
942 _n0
999 _c1175
_d1175